Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TSXV/CANB stock hub

TSXV/CANB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSXV/CANBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.1M

TSX Venture Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSXV/CANB

In the news

Latest news · TSXV/CANB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-15.9

P25 -121.5P50 -40.9P75 0.5

ROIC1

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSXV/CANB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

177

Groups with data

Currency

CAD

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 9.4M
Exchange	TSX Venture Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA13530Q1046
Last refreshed	2026-05-10
Market cap	CAD 2.1M
Price	CAD 0.02
Price currency	CAD
Sector	Healthcare
Sic	2834
Symbol	tsxv/CANB
Website	https://www.canadabis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-60.76%
EV Earnings	-7.34x
EV/EBIT	61.04x
EV/EBITDA	10.24x
EV/FCF	-4.39x
EV/Sales	0.63x
FCF yield	-101.67%
P/B ratio	0.27x
P/S ratio	0.14x
PE Ratio3 Y	22.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	1.03%
EBITDA Margin	3.2%
Gross margin	44.63%
Gross Profit	CAD 6.7M
Gross Profit Growth	-19.85%
Gross Profit Growth Q	-29.8%
Gross Profit Growth3 Y	-1.33%
Gross Profit Growth5 Y	33.1%
Net Income	CAD -1.3M
Net Income Growth Years	0%
Pretax Margin	-7.77%
Profit Margin	-8.53%
ROA	0.38
Roa5y	2.4
ROCE	1.16
ROE	-15.86
Roe5y	0.46
ROIC	1.01
Roic5y	7.34

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-83.35%
Cagr3y	-54.08%
Cagr5y	-39.82%
EPS Growth Years	0
Revenue Growth	-12.84x
Revenue Growth Q	-35.88x
Revenue Growth Years	0x
Revenue Growth3 Y	0.23x
Revenue Growth5 Y	22.12x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.59
Assets	CAD 24.4M
Cash	CAD 938,926
Current Assets	CAD 14.8M
Current Liabilities	CAD 11.1M
Debt	CAD 8.2M
Debt EBITDA	CAD 8.86
Debt Equity	CAD 1.05
Debt FCF	CAD -3.8
Equity	CAD 7.8M
Interest Coverage	0.2
Liabilities	CAD 16.6M
Long Term Assets	CAD 9.6M
Long Term Liabilities	CAD 5.5M
Net Cash	CAD -7.2M
Net Cash By Market Cap	CAD -342
Net Debt EBITDA	CAD 15.01
Net Debt Equity	CAD 0.93
Tangible Book Value	CAD 7.7M
Tangible Book Value Per Share	CAD 0.06
WACC	7.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.33
Inventory Turnover	0.73
Net Working Capital	CAD 5.4M
Quick ratio	0.19
Working Capital	CAD 3.7M
Working Capital Turnover	CAD 5.36

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.01%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-83.33%
200-day SMA	0.05
3Y total return	-90.32%
50-day SMA	0.02
50-day SMA vs 200-day SMA	50under200
5Y total return	-92.11%
All Time High	0.68
All Time High Change	-97.79%
All Time High Date	2019-04-30
All Time Low	0.01
All Time Low Change	50%
All Time Low Date	2026-04-08
ATR	0
Beta	0.56
Beta1y	-0.99
Beta2y	-1.12
Ch YTD	-50
High	0.02
High52	0.1
High52 Date	2025-04-25
High52ch	-84.21%
Low	0.02
Low52	0.01
Low52 Date	2026-04-08
Low52ch	50%
Ma50ch	-37.24%
Price vs 200-day SMA	-69.07%
RSI	38.86
RSI Monthly	32.85
RSI Weekly	29.6
Sharpe ratio	0.16x
Sortino ratio	0.29
Total Return	0.01%
Tr YTD	-50
Tr1m	-40%
Tr3m	-40%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD 154,665
Operating Income Growth	-60.45
Operating Income Growth Q	-71.53
Operating Income Growth3 Y	-57.29
Operating margin	1.03

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	45,837,281%
Net Borrowing	2,288,365
Shares Insiders	3.02%
Shares Out	141,022,815
Shares Qo Q	0%
Shares Yo Y	-0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -2.2M
Average Volume	168,320.9x
Bv Per Share	0.06
CAPEX	CAD -68,742
Ch1m	-40
Ch1y	-83.33
Ch3m	-40
Ch3y	-90.32
Ch5y	-92.11
Ch6m	-66.67
Change	0%
Change From Open	0
Close	0.02
Days Gap	0
Depreciation Amortization	327,058
Dollar Volume	20.55
Earnings Date	2026-04-13
EBIT	CAD 154,665
EBITDA	CAD 481,723
EPS	CAD -0.01
F Score	2
FCF	CAD -2.2M
FCF EV Yield	-22.78x
FCF Per Share	CAD -0.02
Financing CF	2,288,365
Fiscal Year End	July
Founded	2,016
Income Tax	CAD 113,319
Investing CF	-68,742
Is Primary Listing	1
Last Earnings Date	2025-11-28
Last Report Date	2025-10-31
Ma150	0.04
Ma150ch	-59.46%
Ma20	0.02
Ma20ch	-22.28%
Net CF	137,758
Open	0.02
Ppne	9,627,913
Price Date	2026-04-09
Price EBITDA	CAD 4.39
Ptbv Ratio	0.27
Relative Volume	0.01x
Revenue	15,076,174x
Tax By Revenue	0.75x
Tr6m	-66.67%
Volume	1,370
Z Score	0.33

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSXV/CANB pay a dividend?

Capital-return profile for this ticker.

Performance

TSXV/CANB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSXV/CANB?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+3.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

TSXV/CANB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.9

Neutral momentum band

Price vs 200-day MA

-69.1%

50/200-day relationship not available

Beta (5Y)

0.56

Less volatile than the market

Sharpe ratio

0.16

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSXV/CANB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsxv/CANB stock rating?

tsxv/CANB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsxv/CANB analysis?

The full report lives at /stocks/tsxv/CANB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsxv/CANB?

The latest report frames tsxv/CANB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsxv/CANB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.